Tae Min Kim, MD, PhD^1*, Michal Taszner, MD^2*, Seok-Goo Cho, M.D., Ph.D.^3*, Silvana Novelli, MD, PhD⁴, Steven Le Gouill, MD, PhD⁵, Michelle Limei Poon, MBBS, MRCP^6*, Jose C. Villasboas, MD⁷, Rebecca Champion, MD^8*, Emmanuel Bachy, MD, PhD^9*, Stéphanie Guidez, MD^10*, Aránzazu Alonso Alonso, MD^11*, Deepa Jagadeesh, MD¹², Michele Merli, MD^13*, David Tucker, MD^14*, Jingxian Cai^15*, Carolina Leite De Oliveira, PharmD^15*, Min Zhu, PhD^15*, Aafia Chaudhry, MD, MBA, MS^15*, Hesham Mohamed, MD^15*, Srikanth R. Ambati, MBBS, MD^15* and Stefano Luminari, MD¹⁶

¹Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Uniwersyteckie Centrum Kliniczne Klinika Hematologii I Transplantologii, Gdańsk, Poland
³The Catholic University of Korea, Seoul St. Mary’s Hospital Hematology, Seoul, Korea, Republic of (South)
⁴Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
⁵Hospital Group at Institute Curie, Paris, France
⁶Hematology Oncology National University Hospital, Singapore, Singapore
⁷Mayo Clinic Rochester, Rochester, NY
⁸Norton Cancer Institute, Louisville, KY
⁹Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
¹⁰Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France
¹¹Hospital Universitario Quiron Salud Madrid, Madrid, Spain
¹²Cleveland Clinic Main Campus, Cleveland, OH
¹³Hematology, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
¹⁴Royal Cornwall Hospital, Cornwall, United Kingdom
¹⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
¹⁶Division of Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy

Marie José Kersten, MD, PhD¹, Martin Dreyling, MD², Kim M. Linton^3*, Dana Chitu, PhD^4*, Sanne Tonino^5*, Marcel Kap, BSc^6*, Roberto D Liu, BSc^7*, Martine E.D. Chamuleau, MD, PhD⁸, Hein P.J. Visser, MD^9*, Eva De Jongh, MD^10*, Erik WAF Marijt, MD, PhD¹¹, Maria B.L. Leijs, MD^12,13*, Yavuz M. Bilgin, MD PhD^14*, Jan Dürig, MD^15*, Pamela McKay, MBChB, FRCP, FRCPath^16*, Tjeerd J.F. Snijders, MD PhD^17*, Andrew Pettitt, PhD, FRCPath^18,19*, Monique C. Minnema, MD, PhD²⁰, Gabriele Prange-Krex, MD^21*, Maria Cuijpers, MD^22*, Lara H. Böhmer, MD^23*, Lidwine W. Tick, MD, PhD²⁴, Axel Florschütz^25*, Matthijs Silbermann^26*, Rob Fijnheer^27*, Aart Beeker²⁸, Nelleke Tolboom, MD^29*, Cristina Mitea, MD^30*, Anne IJ Arens, MD^31*, Gerben JC Zwezerijnen, MD^32*, Wolfram Klapper^33*, Sarah E. Coupland, MBBS, PhD^34*, Daphne de Jong, MD, PhD^35*, Jeanette K. Doorduijn, MD, PhD³⁶ and Josée M. Zijlstra, MD PhD³⁷

¹Amsterdam University Medical Centers, Location University of Amsterdam; Cancer Center Amsterdam, Amsterdam, Netherlands
²Department of Medicine III, Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany
³Division of Cancer Sciences, University of Manchester and the Christie Hospital, Manchester, United Kingdom
⁴HOVON Data Center, Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, Netherlands
⁵Dept of Hematology, Lymmcare, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
⁶HOVON Data center, Dept. of Hematology, ErasmusMC Cancer Institute, Rotterdam, Netherlands
⁷Amsterdam UMC, University of Amsterdam, Amsterdam, NLD
⁸Amsterdam UMC, Vrije Universiteit Amsterdam, department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands
⁹Hematology, Medisch Centrum Alkmaar, Alkmaar, NLD
¹⁰Department of Hematology, Albert Schweitzer Hospital, Dordrecht, Netherlands
¹¹Hematology, Leiden University Hospital, Leiden, Netherlands
¹²Maasstad Ziekenhuis, Rotterdam, Netherlands
¹³Maasstad Ziekenhuiis, Rotterdam, Netherlands
¹⁴Department of Internal Medicine, Admiraal de Ruijter Hospital, Goes, Netherlands
¹⁵Department of Hematology, Essen University Hospital, Essen, Germany
¹⁶Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹⁷Medisch Spectrum Twente, Enschede, Netherlands
¹⁸The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom
¹⁹University of Liverpool, Liverpool, United Kingdom
²⁰Department of Hematology, University Medical Center, Utrecht, Netherlands, Utrecht, Netherlands
²¹Gemeinschaftspraxis Mohm/Prange-Krex, Dresden, Germany
²²Viecuri Medical Centre, Venlo, NLD
²³Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands
²⁴Maxima Medical Center, Veldhoven, NLD
²⁵Hematology, Klinikum Dessau, Dessau, Germany
²⁶Ter Gooi Hospital, HILVERSUM, NLD
²⁷Meander Medical Center, Department of Internal Medicine, Amersfoort, Netherlands
²⁸Spaarne Ziekenhuis, Hoofddorp, Netherlands
²⁹Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands
³⁰Nuclear Medicine, Maastricht University Medical Center, Maastricht, Netherlands
³¹Radboud University Medical Center, Nijmegen, NLD
³²Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location VUmc, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
³³University Hospital Schleswig-Holstein, Campus Kiel, Kiel, DEU
³⁴Pathology, University of Liverpool, Liverpool, GBR
³⁵Amsterdam UMC, Vrije Universiteit Amsterdam, department of Pathology, Cancer Center Amsterdam, Amsterdam, Netherlands
³⁶Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands
³⁷Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, Amsterdam, Netherlands

Catherine S. Diefenbach, MD¹, Brad S. Kahl, MD², Lalita Banerjee, FRCPath^3*, Andrew K. McMillan, MD⁴, Fiona Miall, MD, FRCPath, MRCP, BMBS^5*, Javier Briones, MD, PhD^6*, Raul Cordoba, MD, PhD⁷, John M. Burke, MD⁸, Jamie Hirata, PharmD⁹, Sunil Sharma, MPH^10*, Lisa Musick, PharmD^9* and Pau Abrisqueta Costa, MD, PhD^11*

¹Perlmutter Cancer Center at NYU Langone Health, New York, NY
²Division of Oncology, Washington University, St Louis, MO
³Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom
⁴Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁵Department of Haematology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
⁶Department of Hematology, Hospital Santa Creu i Sant Pau, Barcelona, Spain
⁷Fundación Jiménez Díaz University Hospital, Madrid, Spain
⁸Rocky Mountain Cancer Centers/US Oncology, Aurora, CO
⁹Genentech, Inc., South San Francisco, CA
¹⁰Syneos Health, Raleigh, NC
¹¹Hospital Vall d’Hebron, Barcelona, Spain

Christopher Melani, MD¹, Rahul Lakhotia, MBBS¹, Stefania Pittaluga, MD, PhD², James D. Phelan, PhD^1*, Jillian Simard, MD¹, Jagan R. Muppidi, MD, PhD^1*, Craig J. Thomas, PhD^3*, Michele Ceribelli, PhD^3*, Frances Anne Tosto, MS^3*, Rafic J. Farah, MD⁴, Seung Tae Lee, MD, PhD⁵, Amynah Pradhan, CRNP-F^1*, Anna Marie Juanitez, RN^1*, Seth M. Steinberg, PhD^6*, Elaine S. Jaffe, MD², Mark Roschewski, MD¹, Louis M. Staudt, MD, PhD¹ and Wyndham H. Wilson, MD, PhD¹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
³Division of Pre-Clinical Innovation Chemistry Technologies, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD
⁴UPMC Hillman Cancer Center, Pittsburgh, PA
⁵University of Maryland Medical Center, Baltimore, MD
⁶Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD

Matthew J. Maurer, DSc¹, Vit K Prochazka, MD, PhD^2*, Christopher R. Flowers, MD³, Lasse Hjort Jakobsen, MSc, PhD^4*, Diego Villa, MD⁵, Caroline E. Weibull, MSc, PhD^6*, Elliot J. Cahn^7*, Alexandra Smith, MS^7*, Herve Ghesquieres, MD, PhD^8*, Robert Kridel, MD⁹, Maher Gandhi, MBChB PhD¹⁰, Chan Yoon Y. Cheah, MD¹¹, Eliza Hawkes, MD¹², John F. Seymour, MBBS, PhD, FRACP¹³, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP¹⁴, Michael Roost Clausen, MD, PhD^15*, Björn E Wahlin, MD, PhD¹⁶, Jonathan W. Friedberg, MD, MMSc¹⁷, Carla Casulo, MD¹⁸, Thomas M. Habermann, MD¹⁹, Yucai Wang, MD, PhD¹⁹, Loretta J. Nastoupil, MD²⁰, Peter De Nully Brown, MD²¹, David Belada, MUDr, PhD^22*, Andrea Janíková, doc., MD, PhD^23*, Heidi Mocikova, MD, Ph.D.^24*, Tomáš Fürst, Dr.^25*, Richard Burack, MD, PhD²⁶, Peter Martin, FRCPC, MD, MS²⁷, Jonathon B. Cohen, MD, MS²⁸, Izidore S. Lossos, MD²⁹, Brad S. Kahl, MD³⁰, Brian K. Link, MD³¹, Karin E. Smedby, MD, PhD^32*, Laurie H. Sehn, MD, MPH³³, Marek Trneny, MD³⁴, Tarec Christoffer Christoffer El-Galaly, MD, DSc^35,36 and James R. Cerhan, MD, PhD¹

¹Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
²Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital In Olomouc, Olomouc, Czech Republic
³Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁴Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
⁵Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
⁶Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁷Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁸Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France
⁹University Health Network, Princess Margaret Cancer Center, Toronto, ON, Canada
¹⁰Department of Haematology, Princess Alexandra Hospital, Mater Research University of Queensland, Brisbane, QLD, Australia
¹¹Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WEA, Australia
¹²Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
¹³Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
¹⁴Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
¹⁵Department of Haematology, Vejle Hospital, Vejle, Denmark
¹⁶Karolinska Institute, Stockholm, Sweden
¹⁷James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
¹⁸Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
¹⁹Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
²⁰The University of Texas MD Anderson Cancer Center, Houston, TX
²¹Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
²²Charles University, Faculty of Medicine, Prague, Czech Republic
²³Department of Hematology and Oncology, Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
²⁴Department of Internal Medicine, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE, Czech Republic
²⁵Department of Mathematical Analysis and Applications of Mathematics, Faculty of Science, Palacký University, Olomouc, Czech Republic
²⁶Department of Pathology and Laboratory Medicine/Hematopathology, University of Rochester Medical Center, Rochester, NY
²⁷Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
²⁸Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
²⁹Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
³⁰Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
³¹Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
³²Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
³³Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and The University of British Columbia, Vancouver, BC, Canada
³⁴1st Department of Internal Medicine - Hematology, General Hospital, Charles University, Prague, Czech Republic
³⁵Department of Hematology and Aalborg Hospital Science and Innovation Center (AHSIC), Aalborg University Hospital, Aalborg, Denmark
³⁶Department of Haematology, Aalborg University Hospital, Aalborg, Denmark

Connie Lee Batlevi, MD, PhD¹, Gilles Salles, MD, PhD², Steven I. Park, MD^3,4, Tycel J. Phillips, MD⁵, Jennifer E. Amengual, MD⁶, David Andorsky, MD^7*, Philip Campbell, MB, ChB^8*, Pamela McKay, MD^9*, John P. Leonard, MD¹⁰, Manu Sondhi, MD, MPH^11*, Yingxue Chen, PhD^11*, Pamela L. Slatcher, MHS, MT, PA^11*, Richard Lin, PhD, MPH^11*, Attila Szanto, MD, PhD^11*, Sara Abbadi, PhD^11* and Franck Morschhauser, MD, PhD^12*

¹Lymphoma Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Charlotte, NC
⁵University of Michigan Medical School, Ann Arbor, MI
⁶Columbia University Irving Medical Center, New York, NY
⁷Rocky Mountain Cancer Centers, Boulder, CO
⁸Barwon Health, University Hospital Greelong, Greelong, VIC, Australia
⁹Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
¹⁰Weill Cornell Medicine, New York, NY
¹¹Epizyme, Inc., Cambridge, MA
¹²Service des Maladies du Sang, CHU Lille, Lille, France